Search Results
Dr. Valentin Goede on Obinutuzumab Versus Rituximab in CLL
Obinutuzumab/chlorambucil gives OS benefit over rituximab in frontline CLL
EHA 2013: Adding obinutuzumab or rituximab to chlorambucil improves chronic lymphocytic leukaemia
Dr. Goede Discusses Obinutuzumab (GA101) in Chronic Lymphocytic Leukemia
Dr. Goede on the Results from the Phase III CLL11 Trial
Rituximab, Obinutuzumab, and Ofatumumab in CLL
Ibrutinib and rituximab shows superior PFS vs. FCR in CLL
Overview of the CLLR3 trial of obinutuzumab
Undetectable MRD after obinutuzumab plus venetoclax in CLL
Dr. Rogers Discusses Obinutuzumab, Ibrutinib, and Venetoclax Combination in CLL
Valentin GOEDE: "CLL and related disorders"
Dr. Flynn on Obinutuzumab for the Treatment of CLL
